Dayer N, Ciocca N, Antiochos P, Lu H, Auberson D, Meier D
Int J Cardiovasc Imaging. 2025; .
PMID: 40085283
DOI: 10.1007/s10554-025-03375-0.
Yassin M, Al Farsi K, Hamad A, Ghasoub R, Alhuraiji A, Mheidly K
Front Med (Lausanne). 2025; 12:1509074.
PMID: 40078401
PMC: 11897515.
DOI: 10.3389/fmed.2025.1509074.
Chong J, Chuah C, Lee C
Int J Mol Sci. 2025; 26(5).
PMID: 40076674
PMC: 11900203.
DOI: 10.3390/ijms26052052.
Houmsse M, Muskara A, Pasca D, Roy A, Sughra S, Ghazi S
Cancers (Basel). 2025; 17(5).
PMID: 40075674
PMC: 11899116.
DOI: 10.3390/cancers17050827.
Dafaalla M, Costa F, Jia H, Wijeysundera H, Rashid M, Graham M
Eur Heart J Open. 2025; 5(2):oeaf012.
PMID: 40070878
PMC: 11892560.
DOI: 10.1093/ehjopen/oeaf012.
In-depth analysis of the safety of CAR-T cell therapy for solid tumors.
Dong J, Wu J, Jin Y, Zheng Z, Su T, Shao L
Front Immunol. 2025; 16:1548979.
PMID: 40066440
PMC: 11891211.
DOI: 10.3389/fimmu.2025.1548979.
Prefectural Survey on Immune Checkpoint Inhibitor-Associated Myocarditis at the Start of the Basic Plan to Promote Cancer Control Programs - Phase 4.
Okura Y, Miura S, Tanabe N, Ozaki K, Kashimura T, Kikuchi A
Circ Rep. 2025; 7(3):176-182.
PMID: 40066210
PMC: 11890297.
DOI: 10.1253/circrep.CR-24-0171.
Cardiovascular toxicity induced by immunotherapy in non-small cell lung cancer: a systematic review and meta-analysis of observational studies.
Sabate-Ortega J, Teixidor-Vila E, Sais E, Hernandez-Martinez A, Montanes-Ferrer C, Coma N
Front Oncol. 2025; 15:1528950.
PMID: 40066100
PMC: 11891047.
DOI: 10.3389/fonc.2025.1528950.
Immune checkpoint inhibitors and myocardial infarction.
Juhasz V, Suero-Abreu G, Neilan T
J Thromb Thrombolysis. 2025; .
PMID: 40064838
DOI: 10.1007/s11239-025-03081-7.
Large left atrial myxoma with synchronous laryngeal squamous cell carcinoma: A case report.
Zhu L, Neo J, Punjabi L, Lai S, Chua Y
World J Cardiol. 2025; 17(2):100952.
PMID: 40061278
PMC: 11886394.
DOI: 10.4330/wjc.v17.i2.100952.
Endo- and myocarditis as a severe complication of immune-related adverse event treatment: a case report.
Van den Bosch L, Vanclooster P, Van Offenwert J, Teuwen L, Franssen C
Eur Heart J Case Rep. 2025; 9(3):ytaf058.
PMID: 40061108
PMC: 11886836.
DOI: 10.1093/ehjcr/ytaf058.
Midostaurin-associated perimyocarditis: a case report of severe cardiotoxicity of novel targeted treatments for acute myeloid leukaemia and review of the literature.
Kalkan A, Pennig L, Pfister R, Cornely O, Stemler J
Eur Heart J Case Rep. 2025; 9(3):ytaf044.
PMID: 40061103
PMC: 11886857.
DOI: 10.1093/ehjcr/ytaf044.
Management of Stable Coronary Artery Disease and Acute Coronary Syndrome in Patients with Cancer.
Desai S, Aziz M, Marmagkiolis K, Cilingiroglu M, Iliescu C, Ynalvez L
Curr Cardiol Rep. 2025; 27(1):65.
PMID: 40035980
DOI: 10.1007/s11886-025-02214-x.
Guideline for the Use of Natriuretic Peptides in the Early Diagnosis and Management of Heart Failure in Primary Care .
Celik A, Ozturk G, Cavusoglu Y, Ardic C, Nalbantgil S, Arica S
Balkan Med J. 2025; 42(2):94-107.
PMID: 40033605
PMC: 11881534.
DOI: 10.4274/balkanmedj.galenos.2025.2024-12-110.
Doxorubicin-induced cardiometabolic disturbances: what can we do?.
Avagimyan A, Pogosova N, Rizzo M, Sarrafzadegan N
Front Clin Diabetes Healthc. 2025; 6:1537699.
PMID: 40027901
PMC: 11868090.
DOI: 10.3389/fcdhc.2025.1537699.
Diagnostic and Prognostic Value of Cardiac Magnetic Resonance for Cardiotoxicity Caused by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Li J, Li Y, Tao L, Zhang C, Zuo Z
Rev Cardiovasc Med. 2025; 26(2):25508.
PMID: 40026491
PMC: 11868891.
DOI: 10.31083/RCM25508.
Cardiovascular disease risk in cancer survivors: a population-based cohort study from the UK Biobank, and meta-analysis of cohort studies.
Shu C, Mei Z, Yu B, Wang X, Wu H, Li C
BMJ Public Health. 2025; 3(1):e001303.
PMID: 40017970
PMC: 11816107.
DOI: 10.1136/bmjph-2024-001303.
Cardiac MRI for differentiating chemotherapy-induced cardiotoxicity in sarcoma and breast cancer.
Ibrahim E, Chaudhary L, Cheng Y, Sosa A, An D, Charlson J
Radiol Oncol. 2025; 59(1):79-90.
PMID: 40014780
PMC: 11867570.
DOI: 10.2478/raon-2025-0012.
The predictive value of changes in 18F-FDG PET/CT cardiac uptake patterns and metabolic parameters for anthracycline based chemotherapy induced cardiac toxicity in lymphoma patients.
Lin R, Tian A, Wang Y, Wang X, Yuan X, Yu J
PLoS One. 2025; 20(2):e0319442.
PMID: 40014616
PMC: 11867325.
DOI: 10.1371/journal.pone.0319442.
Optimal follow-up duration of cardiac function tests in patients treated with trastuzumab: an analysis using the Japanese Adverse Drug Event Report (JADER) database.
Makihara K, Kongo K, Motomura K, Kimoto D, Yamamoto Y, Tanihata M
Int J Clin Oncol. 2025; .
PMID: 40009314
DOI: 10.1007/s10147-025-02727-z.
